Skip to content
  • About Us
    • Careers
  • Services
    • Sell Side Advisory
    • Buy Side Advisory
    • Transaction Planning & Advisory
    • Capital Raising
  • Industry Expertise
    • Business Services
    • Consumer, Food & Retail
    • Healthcare
    • Industrials
    • Plastics & Packaging
    • Software & Technology
  • Transactions
  • Team
  • News & Insights
    • Industry Updates
    • News
    • Perspectives
Menu
  • About Us
    • Careers
  • Services
    • Sell Side Advisory
    • Buy Side Advisory
    • Transaction Planning & Advisory
    • Capital Raising
  • Industry Expertise
    • Business Services
    • Consumer, Food & Retail
    • Healthcare
    • Industrials
    • Plastics & Packaging
    • Software & Technology
  • Transactions
  • Team
  • News & Insights
    • Industry Updates
    • News
    • Perspectives
Contact

Industry Updates

  • Back to News & Insights

Medical Technology M&A Pulse – Q3 2020

  • November 23, 2020
  • Industry Updates
  • Healthcare, Medical Technology
Medical Technology: Searching For Stability In The New Normal
  • 2020 has been a year like no other! In the center of it all medical equipment and consumable manufacturers, diagnostic test providers, and pharmaceutical/biotechnology developers have been working tirelessly in the effort to combat COVID-19. In addition to helping treat those who have contracted COVID-19, these companies have also been critical players in the push to develop and manufacture massive numbers of diagnostic tests, as well as to test and validate potential vaccines for the disease.
  • Like nearly all publicly traded U.S. equities, the stock performance of PMCF’s four Medical Technology indices turned negative during the spring months, with a rapid decline in valuations, followed by varying levels of recovery and growth. Aside from the Orthopedic Medical Device index, a sector particularly challenged by the effects of COVID-19 related shutdowns, the other indices outperformed the Dow Jones Industrial Average over the last twelve months but underperformed the S&P 500 Growth Index.
  • While PMCF’s Medical Technology indices reacted sharply to previous COVID-19 milestones and events, the likely effect of the recent second wave spike in cases and vaccine data readouts remains unclear.
Read Medical Technology M&A Pulse Q3 2020 Full Report

Download Preview

Stay Informed

Subscribe to our newsletter for the latest industry updates

Subscribe

Recent Publications

Human Capital Management M&A Pulse – Q1 2023
Software & Technology M&A Pulse – Q1 2023
Plastics M&A Update – March 2023
Packaging M&A Update – March 2023
Plastics M&A Update – February 2023
Contact

Follow Us On

Cfi Logo White 94x94 On About

Home

  • About
  • Team
  • Careers

Services

  • Sell Side M&A Advisory
  • Buy Side M&A Advisory
  • Capital Raising
  • Transaction Planning & Strategic Advisory

Industry Expertise

  • Business Services
  • Consumer, Food & Retail
  • Healthcare
  • Industrials
  • Plastics & Packaging
  • Software & Technology

News & Insights

  • Transactions
  • News
  • Industry Updates
  • Perspectives

PMCF is a trade name for PMCF Advisors, LLC and P&M Corporate Finance, LLC. The term “PMCF” refers to one or more of these legally separate and independent advisory practices. P&M Corporate Finance, LLC provides capital raising and private placement services that require registration as a broker-dealer.

©2023 PMCF

  • Member SIPC​
  • Member FINRA
  • FINRA Broker Check
  • Business Continuity Plan​
  • Disclaimer​
  • Privacy Policy​